Literature DB >> 8226419

Antibiotic resistance of faecal Enterobacteriaceae isolated from healthy volunteers, a 15-week follow-up study.

N London1, R Nijsten, A vd Bogaard, E Stobberingh.   

Abstract

From 25 March to 1 July 1991 faecal samples from healthy volunteers of two cities and their rural surroundings, Weert (n = 91) and Roermond (n = 96) were collected weekly and analysed for the presence of Enterobacteriaceae, resistant to ampicillin, ciprofloxacin, nalidixic acid, neomycin, nitrofurantoin, oxytetracycline, sulphamethoxazole or trimethoprim. In total, 682 and 690 samples from Weert and Roermond, respectively, were analysed for the prevalence and the degree of resistance to each antimicrobial agent. The mean prevalence of resistance of the samples from Weert varied from 28% +/- 12 (mean +/- S.D.) for ampicillin to 0.1% +/- 1 (range 0-2%) for ciprofloxacin. For Roermond the prevalence of resistance varied from 41% +/- 7% for sulphamethoxazole to 0% for ciprofloxacin. The high degree of resistance (i.e. > 50% of the faecal flora of one particular individual) varied from 8% +/- 4 for sulphamethoxazole to 2% +/- 2 for trimethoprim for Weert. For Roermond the figures varied from 14% +/- 4 for sulphamethoxazole to 0.3% +/- 1 (range 0-2%) for nalidixic acid. High degrees of resistance were not found for ciprofloxacin and nitrofurantoin in either city. In Weert ampicillin-resistant Enterobacteriaceae were isolated from 69/91 individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226419     DOI: 10.1093/jac/32.1.83

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Carriage of antibiotic-resistant Escherichia coli by healthy volunteers during a 15-week period.

Authors:  N London; R Nijsten; A van der Bogaard; E Stobberingh
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

2.  A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora.

Authors:  M Osterblad; A Hakanen; R Manninen; T Leistevuo; R Peltonen; O Meurman; P Huovinen; P Kotilainen
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization.

Authors:  P Margreet G Filius; Inge C Gyssens; Irma M Kershof; Patty J E Roovers; Alewijn Ott; Arnold G Vulto; Henri A Verbrugh; Hubert P Endtz
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.

Authors:  J J Calva; J Sifuentes-Osornio; C Cerón
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

5.  The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela.

Authors:  H J van de Mortel; E J Jansen; G J Dinant; N London; E Palacios Prü; E E Stobberingh
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

6.  Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphism.

Authors:  Nienke Bruinsma; Rob J L Willems; Anthony E van den Bogaard; Marga van Santen-Verheuvel; Nancy London; Christel Driessen; Ellen E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.